Original Papers

27th Annual Symposium of the International Cannabinoid Research Society, Montreal, Canada, June 22-27, 2017 [Abstracts (8.3MB)]
Nielsen et al. (2017) Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. Neuropsychopharmacology, 42(9):1752-1765 [PMID: 28327548] PAIN
Barrie et al. (2017) Endocannabinoids in arthritis: current views and perspective. International Journal of Rheumatic Disease, 20(7):789-797 [PMID: 28736968] PAIN ARTHRITIS
Koo CM, Kang HC (2017) Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy? Journal of Epilepsy Research, 7(1):16-20 EPILEPSY

Please contact AusCann via medicalenquiries@auscann.com.au for further information, education or support.

DISCLAIMER

The information on this website is provided for the purpose of disseminating information pertaining to cannabinoid medicines and is targeted to health professionals, not the general public. Nothing on this website is intended to be used as medical advice and it is not intended to be used to prevent, diagnose, treat or cure any disease or condition. The information on this website has been compiled from a variety of sources and should not be considered complete. It is provided on an ‘as is’ basis, without any warranties, either express or implied.

The website contains links to external sites. AusCann takes reasonable care in selecting linking websites but accepts no responsibility for material contained on an external site. It is the responsibility of the user to ensure make their own decisions regarding accuracy, currency, reliability and correctness of information on the external sites. The links are provided for convenience and do not constitute an endorsement of any third party products or services. Views put forward on third party websites do not necessarily match the views of the Company.